Representative before the EPO

Employment test 51 - 200 employees
Company dna kilburn and strode llp
operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Nicholas John Lee has worked on the following 118 EPO patent applications which have been published in the last five years:

EP11735347

A25 BACTERIOPHAGE LYSIN

IPC classification:
C12N 9/26, C12Q 1/14, G01N 33/50
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP11771411

PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 38/40, A61K 39/42, A61P 31/04, A61P 31/12
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION WITHDRAWN
EP11771412

ECZEMA TREATMENT

IPC classification:
A61K 35/20, A61K 38/17, A61K 38/40, A61K 39/395, A61P 17/00, A61P 37/08
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION WITHDRAWN
EP11799995

METHOD OF TREATING GRAFT VERSUS HOST DISEASE

IPC classification:
A61K 35/28, A61P 37/06, C12N 5/077, C12N 5/0789
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
GRANT OF PATENT INTENDED
EP11799996

TREATMENT OF T-CELL MEDIATED IMMUNE DISORDERS

IPC classification:
A61K 35/28, A61P 37/06, C12N 5/077, C12N 5/0789
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
EXAMINATION IN PROGRESS
EP12189792

Automated system for storing, retrieving and managing samples

IPC classification:
B01L 3/00, B01L 9/00, F25D 25/00, G01N 35/04
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP11839434

ACTRIIA BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/395, C07K 16/00, C07K 16/28
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP11758816

DETECTION DEVICE FOR DETECTING ANALYTES IN LIQUID SPECIMEN

IPC classification:
B01L 3/00, G01N 33/50, G01N 33/53
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP10793010

T CELL RECEPTORS

IPC classification:
C07K 14/705
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION WITHDRAWN
EP12178903

Activin-ActRIIa Antagonists and Uses for Treating or Preventing Breast Cancer

IPC classification:
A61K 38/17, A61K 38/18, A61P 35/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP12756974

COMPOSITIONS AND METHODS FOR TREATMENT OF INFECTIONS

IPC classification:
A01N 25/34
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP12771191

POLYCLONAL ANTIBODY COMPOSITIONS

IPC classification:
C07K 16/00, C12P 21/08
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774024

METHOD OF DIAGNOSING CANCER

IPC classification:
C12Q 1/68
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP12774531

CERCLAGE SUTURE REMOVAL DEVICE

IPC classification:
A61B 17/10
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION WITHDRAWN
EP11778983

A WATER SOLUBLE COMPOSITION COMPRISING CURCUMIN HAVING ENHANCED BIOAVAILABILITY AND PROCESS THEREOF

IPC classification:
A61K 31/12, A61K 47/22, A61K 47/26, A61K 47/38, A61K 47/44, A61P 25/24
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
PATENT GRANTED
EP12750085

WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF

IPC classification:
A61K 38/16, C07K 14/00
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP12797008

COMPOSITIONS AND METHODS FOR INCREASING SERUM HALF-LIFE

IPC classification:
A61K 38/17, A61P 29/00, A61P 37/00, C07K 14/715, C07K 14/725, C07K 19/00, C12N 15/12, C12N 15/62
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12803202

COMPOSITIONS FOR DEPOSITING AGENTS USING HIGHLY VOLATILE SILICONE SOLVENTS

IPC classification:
A61Q 5/12
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP12807376

METHODS AND COMPOSITIONS FOR ASSIGNING LIKELIHOOD OF ACUTE KIDNEY INJURY PROGRESSION

IPC classification:
A61K 48/00
Applicant:
Alere San Diego Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12807117

METHODS OF TREATING OR PREVENTING RHEUMATIC DISEASE

IPC classification:
A61K 35/28, A61P 19/02, A61P 37/06, C12N 5/077, C12N 5/0789
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
EXAMINATION IN PROGRESS
EP12815284

ENZYMES FOR DEGRADING ORGANOPHOSPHATES

IPC classification:
A61K 38/46, B09C 1/10, C07K 14/195, C07K 17/00, C07K 19/00, C12N 9/14, C12N 15/29, C12N 15/55, C12Q 1/34
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP12822080

METHODS AND COMPOSITIONS FOR MONITORING HEART FAILURE

IPC classification:
G01N 33/53
Applicant:
Alere San Diego Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP11867338

PYRIMIDOPYRIMIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/519, A61K 31/5377, A61K 31/541, A61K 31/551, A61P 35/00, A61P 35/02, C07D 487/04
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12827869

COMPOSITIONS AND METHODS THEREOF FOR ORAL ADMINISTRATION OF DRUGS

IPC classification:
A01N 43/04, A61K 31/70, A61K 31/715
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP12833356

METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE DISEASES, DISORDERS AND ASSOCIATED PROCESSES

IPC classification:
A61B 6/00, G01N 33/534, G01T 1/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP12836798

2-HYDROXYHIPPURIC ACID ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE

IPC classification:
A61K 39/385
Applicant:
Alere San Diego Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12848661

DEVICES AND METHODS FOR DETECTION OF PANTON-VALENTINE LEUKOCIDIN (PVL)

IPC classification:
G01N 33/53
Applicant:
Alere San Diego Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP12835727

ANIMAL FEED COMPOSITION

IPC classification:
A23K 1/16, A23K 1/17, A23K 1/18
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP13194721

EIF4E Regulon-based diagnostics

IPC classification:
G01N 33/50, G01N 33/574
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP13181265

Methods of modulating the negative chemotaxis of immune cells

IPC classification:
A01N 63/00, A61K 38/17
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12778188

METHODS AND COMPOSITIONS FOR RAPID TRANSBUCCAL DELIVERY OF ACTIVE AGENTS

IPC classification:
A61K 9/00, A61K 31/465
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12842537

METHOD OF TREATING OR REDUCING EFP

IPC classification:
A61K 38/48
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14166241

Activin-ActRIIA antagonists in use for promoting bone growth

IPC classification:
A61K 38/17, C07K 14/705, C12N 5/10
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP11771410

COLD TREATMENT

IPC classification:
A61K 38/40, A61K 39/42, A61P 31/04, A61P 31/12
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14175663

Variants derived from ActRIIB and uses therefor

IPC classification:
A61K 38/00, A61K 38/17, C07K 14/705, C07K 14/71, C07K 14/72, C07K 16/18
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13740927

PROTEASOME ACTIVITY MODULATING COMPOUNDS

IPC classification:
A61K 31/519
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP12792873

METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES

IPC classification:
A61K 35/28, A61K 38/21, A61P 37/06, C12N 5/077, C12N 5/0775, C12N 5/0789
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
EXAMINATION IN PROGRESS
EP13184611

Antibody therapy for use in the digestive tract

IPC classification:
C07K 16/24
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14171201

Romidepsin-based treatments for cancer

IPC classification:
A61K 38/00, A61K 38/07
Applicant:
Celgene Corporation
Applicant:
Sandoz GmbH
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13749013

COMPOSITIONS AND METHODS FOR MONITORING BIOMETRIC INDICATORS

IPC classification:
A61B 6/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
PATENT GRANTED
EP12792615

METHOD OF TREATING A MAMMALIAN TEAT AND RELATED COMPOSITIONS

IPC classification:
A01J 7/00, A01J 7/04, A61K 9/00, A61K 9/06, A61K 9/08, A61K 31/194, A61K 31/235, A61K 31/5415, A61K 45/06, A61K 47/02, A61K 47/10, A61K 47/32, A61K 47/36, A61K 47/38, A61P 9/00, A61P 31/00, A61P 31/04
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP13764228

POTENTIATING ANTIBODY-INDUCED COMPLEMENT-MEDIATED CYTOTOXICITY VIA PI3K INHIBITION

IPC classification:
A61K 39/00, A61K 39/395
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13179218

Assay detection systems and methods

IPC classification:
G01N 21/84
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14186917

Poly(Lactide-Co-Glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar.

IPC classification:
A61K 9/10, A61K 9/50, A61K 38/22, A61K 38/26, A61K 47/26, A61K 47/38
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP13775350

MICROFLUIDIC DEVICE, SYSTEM AND METHOD

IPC classification:
G01N 33/53
Applicant:
Alere San Diego Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP13781342

QUANTITATION OF BIOMARKERS FOR THE DETECTION OF PROSTATE CANCER

IPC classification:
G01N 33/574
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13186689

Automated system for storing, retrieving and managing samples

IPC classification:
B01L 3/00, B01L 9/00, F25D 25/00, G01N 35/00, G01N 35/02, G01N 35/04
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13780717

LASER JOINING DEVICE

IPC classification:
B23K 26/20
Applicant:
Alere San Diego Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13724880

PROPAGATION OF STRELITZIA (BIRD OF PARADISE)

IPC classification:
A01H 4/00
Applicant:
University of Limpopo
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
PATENT GRANTED
EP13767323

MICROFLUIDIC PUMP

IPC classification:
F04B 43/12
Applicant:
Alere San Diego Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14199949

Recombinant N-glycosylated proteins from procaryotic cells

IPC classification:
C07K 14/205, C07K 14/25, C12N 9/10, C12N 15/70, C12P 21/00
Applicant:
ETH Transfer
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13797704

SUSTAINED DELIVERY OF MOLECULES USING PEPTIDE SURFACTANTS AND USES THEREOF

IPC classification:
A61K 9/51, A61K 38/08
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13801437

LIGANDS MODIFIED BY CIRCULAR PERMUTATION AS AGONISTS AND ANTAGONISTS

IPC classification:
C07K 14/52, C12P 21/04, C12P 21/06
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP13157694

Variants derived from ActRIIB and uses therefor

IPC classification:
A61K 38/00, C07K 16/18
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13784126

VACCINE AND USES THEREOF

IPC classification:
A61K 38/00, A61K 39/00, A61P 37/02, A61P 37/04, A61P 37/06, A61P 37/08, C12N 15/09, C12N 15/63
Applicant:
University of Sydney
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION WITHDRAWN
EP13756743

INDUCIBLE COEXPRESSION SYSTEM

IPC classification:
C12N 15/70
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
PATENT GRANTED
EP13829140

DIGITAL TO BIOLOGICAL CONVERTER

IPC classification:
A61P 31/00, C07K 14/01, C12N 15/00, C12N 15/09
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP13830767

COMPOSITION FOR THE TREATMENT OF MIGRAINE HEADACHES

IPC classification:
A61K 31/165, A61K 31/375, A61K 33/14
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14195896

Method and apparatus for producing dry particles

IPC classification:
A61K 9/16, B01D 1/18
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13844132

A FAMILY OF SYNTHETIC POLYNUCLEOTIDE-BINDING PEPTIDES AND USES THEREOF

IPC classification:
C07K 16/00, C12P 21/08
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13845634

METHOD OF PREPARING RESIN TINCTURES

IPC classification:
A61K 31/155, A61K 47/00, A61K 47/30, A61P 17/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13849751

DEVICE

IPC classification:
G01N 1/10
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13852608

ULTRA LOW DENSITY PULMONARY POWDERS

IPC classification:
A61K 9/16, A61K 39/00, A61P 11/06
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13852876

HIGH DOSE LEVODOPA CAPSULES FOR PULMONARY USE

IPC classification:
A61K 9/12, A61K 31/137, A61P 25/16
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13859213

DUAL CHAMBER APPLICATOR

IPC classification:
A61J 1/06, A61J 7/00, A61M 37/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13853467

DOSATOR FOR FILLING A CAPSULE WITH POWDER

IPC classification:
B65B 1/04, B65B 31/00, B65B 43/42
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13811256

METHOD FOR PREDICTING THE OFF-TARGET BIDING OF A PEPTIDE WHICH BINDS TO A TARGET PEPTIDE PRESENTED BY A MAJOR HISTOCOMPATIBILITY COMPLEX

IPC classification:
C07K 14/725, G01N 33/50, G01N 33/68
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14745418

PHASED INTRODUCTION OF LITHIUM INTO THE PRE-LITHIATED ANODE OF A LITHIUM ION ELECTROCHEMICAL CELL

IPC classification:
H01M 4/13
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14759539

UTERINE COMPRESSION DEVICES AND METHODS

IPC classification:
A61F 5/34
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14763738

IMMUNE MODULATION

IPC classification:
A61K 31/711, A61K 31/713, A61K 39/35, A61P 37/08, C12N 7/01, C12N 15/29, C12N 15/62
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14768400

MULTI-LAYERED INJECTABLE SELF-ASSEMBLING PEPTIDE SCAFFOLD HYDROGELS FOR LONG-TERM SUSTAINED RELEASE OF HUMAN ANTIBODIES

IPC classification:
A61K 9/10, A61K 38/00, C07K 7/00, C07K 16/00
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14765818

LOW-GLYCERIN FORMULATIONS FOR HIV TREATMENT AND PREVENTION

IPC classification:
A61K 9/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14779100

HUMANIZED ANTI-N2 ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15001499

METHODS FOR TREATING ADHESIVE CAPSULITIS

IPC classification:
A61K 38/48
Applicant:
The Research Foundation for The State University of New York
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14788205

IN SITU INTERACTION DETERMINATION

IPC classification:
C12N 15/11, C12Q 1/68
Applicant:
President and Fellows of Harvard College
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP11823058

DEVICE FOR READING ASSAY RESULTS ON TEST CARRIER

IPC classification:
G01N 21/47, G01N 21/77
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION WITHDRAWN
EP13721243

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

IPC classification:
C07K 14/00, C07K 16/28
Applicant:
Teva Pharmaceuticals Australia Pty Ltd
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP15175245

ANTIBODY THERAPEUTICS WITH LOCAL ACTIVITY IN THE DIGESTIVE TRACT

IPC classification:
A61K 39/395, A61P 29/00, C07K 16/24
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14801255

METHODS AND COMPOSITIONS FOR THE DISRUPTION OF BIOFILMS AND TREATMENT OF DISORDERS CHARACTERIZED BY THE PRESENCE OF BIOFILMS

IPC classification:
A61K 31/194, A61K 33/02, A61P 11/12, A61P 31/00, A61P 31/04
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP15178550

METHOD FOR TREATING OR PREVENTING A PANCREATIC DYSFUNCTION

IPC classification:
A61K 35/12, A61K 35/39, A61P 1/18, A61P 5/48, C12N 5/02, C12N 5/077
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP15190349

FUNGICIDAL COMPOSITIONS

IPC classification:
A01N 63/02, A01N 65/00, A01N 65/08, A01N 65/20, A01P 3/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14730952

RETRO POLYPEPTIDES FOR ACTIVATION IMMUNITY TO CANCER AND VIRAL INFECTION

IPC classification:
C07K 14/47
Applicant:
Imperial Innovations Limited
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Agent:
Sterling IP
Status:
EXAMINATION IN PROGRESS
EP14806846

SELECTIN INHIBITORS, COMPOSITION, AND USES RELATED THERETO

IPC classification:
A61K 38/10, A61P 7/02, A61P 9/10, C07K 7/08
Applicant:
Beth Israel Deaconess Medical Center Inc
Applicant:
Emory University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14811033

SYSTEMIC IN VIVO DELIVERY OF OLIGONUCLEOTIDES

IPC classification:
A61K 31/7088
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14813398

IMMUNOTHERAPY COMPOSITION AND USE THEREOF

IPC classification:
A61K 35/74, A61K 39/02, A61P 11/06, A61P 37/08
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14814208

PATHOGEN BINDING AGENTS CONJUGATED TO RADIOISOTOPES AND USES IN IMAGING AND THERAPEUTIC APPLICATIONS

IPC classification:
A61K 39/395, A61K 47/48, A61K 51/02, A61K 51/08
Applicant:
Emory University
Applicant:
Georgia Tech Research Corporation
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP11799993

DIAGNOSIS AND TREATMENT OF BRAIN TUMORS

IPC classification:
A61K 39/00, C07K 16/28, G01N 33/50, G01N 33/574, G01N 33/74
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15194450

POLYMER BASED RADIONUCLIDE CONTAINING PARTICULATE MATERIAL

IPC classification:
A61K 51/06, A61K 51/12, A61P 35/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15180646

COMPOSITIONS FOR TREATING OR PREVENTING OBESITY AND INSULIN RESISTANCE DISORDERS

IPC classification:
A61K 31/7048, A61K 31/7052, A61P 3/00, A61P 3/10
Applicant:
President and Fellows of Harvard College
Applicant:
The General Hospital Corporation
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14761391

T CELL RECEPTORS

IPC classification:
C07K 14/05
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP11721486

COMPOUNDS

IPC classification:
A61K 31/538, A61K 31/553, A61P 25/28, C07D 413/04, C07D 498/04
Agent:
Multiple attorneys, Kilburn & Strode LLP
Agent:
Matthew William Rodgers, BTG International Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14761757

ENGINEERED TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR (TALE) DOMAINS AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
President and Fellows of Harvard College
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14842255

FC-CONTAINING MOLECULES EXHIBITING PREDICTABLE, CONSISTENT, AND REPRODUCIBLE GLYCOFORM PROFILES

IPC classification:
C07K 16/00
Applicant:
Amgen Inc
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP15185229

METHOD OF USING NON-RARE CELLS TO DETECT RARE CELLS

IPC classification:
G01N 33/574
Applicant:
The Scripps Research Institute
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14845345

BODY CORE TEMPERATURE COOLING DEVICE

IPC classification:
A61M 16/00
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP15199387

VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR

IPC classification:
A61K 38/00, A61K 38/17, C07K 14/705, C07K 14/71, C07K 14/72, C07K 16/18
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION PUBLISHED
EP14852529

METHODS AND COMPOSITIONS FOR REGULATORY T-CELL ABLATION

IPC classification:
A61K 39/395, C12N 5/071
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP15201016

PULMONARY DELIVERY OF TRIPTAN

IPC classification:
A61K 9/00, A61K 31/4045
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION PUBLISHED
EP14792441

VECTORS FOR TRANSGENE EXPRESSION

IPC classification:
C12N 15/86
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14858152

METHODS AND COMPOSITIONS FOR INDUCING REGULATORY T-CELL GENERATION

IPC classification:
C12N 5/0783
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP13161929

PULMONARY DELIVERY FOR LEVODOPA

IPC classification:
A61K 9/16, A61K 9/72, A61K 31/137, A61K 31/198, A61K 31/70, A61P 25/16
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
PATENT GRANTED
EP14821823

MODIFIED P450 REDUCTASE WITH N-TERMINAL DELETIONS AND ENDOPLASMIC RETICULUM RETENTION TAG

IPC classification:
C12N 9/02
Applicant:
De Montfort University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14871728

SELF-FUELED PARTICLES FOR PROPULSION THROUGH FLOWING AQUEOUS FLUIDS

IPC classification:
A61K 9/14, A61K 47/02, A61L 29/10, A61P 7/02, A61P 7/04, C01F 11/18, C12N 11/14
Applicant:
The University of British Columbia
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14872645

COMPOSITIONS FOR DRUG ADMINISTRATION

IPC classification:
A61K 31/485
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14809696

T CELL RECEPTOR BINDING TO ALWGPDPAAA, DERIVED FROM HUMAN PRE-PRO INSULIN (PPI) PROTEIN

IPC classification:
C07K 14/725
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP16161468

INJECTABLE SUSPENSIONS HAVING IMPROVED INJECTABILITY PROPERTIES

IPC classification:
A61K 9/16, A61K 31/10, A61K 47/00, A61K 47/34, A61K 47/38
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP16165085

METHODS FOR ANALYZING METHYLATED CPG ISLANDS AND GC RICH REGIONS

IPC classification:
C07H 21/04, C12Q 1/68
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION PUBLISHED
EP15746077

EXPRESSION OF CHIMERIC POLYPEPTIDE WITH VARIABLE LYMPHOCYTE RECEPTORS ON IMMUNE CELLS AND USES FOR TREATING CANCER

IPC classification:
C07K 14/54, C07K 14/705, C07K 19/00, C12N 5/0783, C12N 9/02, C12N 9/10, C12N 15/63
Applicant:
Emory University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP16164650

METHODS AND COMPOSITIONS FOR RAPID TRANSBUCCAL DELIVERY OF ACTIVE AGENTS

IPC classification:
A61K 9/00, A61K 31/465
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION PUBLISHED
EP16176249

BIFUNCTIONAL POLYPEPTIDES

IPC classification:
A61K 38/00, A61K 38/17, C07K 14/705, C12N 15/62
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
APPLICATION PUBLISHED
EP15777056

TREATMENT OF NEURODEGENERATIVE DISEASES WITH ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS AND COMPOSITIONS RELATED THERETO

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/4245, A61K 31/433, A61K 47/38, C07D 271/12, C07D 285/14
Applicant:
Emory University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15776775

ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS FOR MANAGING CANCER AND COMPOSITIONS RELATED THERETO

IPC classification:
A61K 31/52, A61P 35/00, C07D 473/04, C07D 473/06
Applicant:
Emory University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14889874

RAPID RELIEF OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE

IPC classification:
A61K 9/14, A61K 9/48, A61K 31/198
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Agent:
Anna-Louise Hally, F. R. Kelly & Co.
Status:
EXAMINATION REQUESTED
EP15785576

SELECTIVE CHEMOTHERAPY TREATMENTS AND DIAGNOSTIC METHODS RELATED THERETO

IPC classification:
A61K 31/282, A61K 31/4184, A61K 33/24, A61K 48/00, A61P 35/00
Applicant:
Emory University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15786588

SYSTEMS AND METHODS FOR TISSUE TREATMENT

IPC classification:
A61M 5/00, A61M 5/158
Applicant:
Emory University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15786773

HUMANIZED VARIABLE LYMPHOCYTE RECEPTORS (VLR) AND COMPOSITIONS AND USES RELATED THERETO

IPC classification:
C07K 14/705, C07K 14/725, C07K 19/00, C12N 15/62, C12N 15/63
Applicant:
Emory University
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15841542

METHODS FOR DIAGNOSIS, PROGNOSIS AND MONITORING OF BREAST CANCER AND REAGENTS THEREFOR

IPC classification:
C12Q 1/68
Agent:
Nicholas John Lee, Kilburn & Strode LLP
Status:
Request for examination was made

Please Sign in to use this feature